Methods: A retrospective, single-center database was reviewed for 22 AVFs created from 2012 to 2016 with the JuxtaBahn technique. These patients were treated at a single academic institution. A 6-mm Â 2.5-cm or 5.0-cm Viabahn endograft was deployed within the cephalic vein just distal to the anastomosis at the time of AVF creation. At the heel of the anastomosis, the anchoring suture was placed incorporating the artery, vein, and the graft. The hood of the anastomosis comprised native vein, and the remaining anastomosis was sutured in the standard end-toside fashion. Follow-up data were obtained from the electronic medical record.
Objectives: Safe delivery of large endovascular devices can be problematic in patients with inadequate iliofemoral access. We describe the technique and outcomes using carotid access for endovascular device delivery in patients with inadequate iliofemoral access.
Methods: Between January 2015 and January 2017, 60 patients presented with ascending aortic (n ¼ 3; Fig A) , descending aortic (n ¼ 3), or aortic valve (n ¼ 54) pathology who were poor candidates for conventional surgery. In addition, they had inadequate iliofemoral access for large endovascular device delivery. Vascular surgery provided carotid access for device delivery, which included direct exposure of the proximal common carotid artery at the level of the omohyoid muscle (Fig, B) , modification/shortening of the 14F to 22F device delivery sheath (Fig, C) , and intraoperative electroencephalographic monitoring to guide the need for femoraleto-carotid shunting during device delivery. Preoperative imaging included carotid duplex and computed tomography angiography of chest and lower neck.
Results: Right (32) and left (28) carotid access were both used for delivery of ascending (3) or descending aortic (3) covered stents or transcatheter aortic valves (54). Median age was 82 (range, 69-94) years with 50% (30 of 60) women. Procedural success was 100%. No patient required femoral-to-carotid shunting, and in 98% (59 of 60), a transverse carotid arteriotomy with primary repair was used (Fig, D) . In-hospital/30-day mortality was 5% (3 of 60). All patients were extubated in the operating room without any operative neurologic complications. Perioperative strokes occurred in two patients (3.3%) who had transcatheter aortic valve replacements. One stroke occurred on postoperative day 4 and involved a retinal artery occlusion on the carotid access side, and one stroke involved the contralateral hemisphere to carotid access. Median length of stay was 3 days (range 1-9 days) and 96.5% (55 of 57) of surviving patients were discharged to home. With a median follow-up of 12 months (range 1-24 months), survival remains 92% (55 of 60) with no late carotid access complications or strokes.
Conclusions: Delivery of large endovascular devices in patients with inadequate iliofemoral access can be safely performed using carotid access by incorporating a cerebral protection strategy guided by intraoperative electroencephalographic EEG monitoring and facilitated by vascular surgery.
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